Removing Barriers in the HCV Cascade of Care

Slides:

Advertisements

Similar presentations

The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.

Advertisements

Global Hepatitis C Guidelines 2014: recommendations for a public health approach Gottfried Hirnschall.

V.E.I.L. Liver Cancer Prevention. 1. Vaccination Birth dose + 2 Universal for those not already chronics Screening pregnant women Catch up vaccination.

Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013.

Module 3: HCV prevalence and course of HCV infection.

Overview National Hepatitis B Data

Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.

Sara Stevenson Hepatitis B Nurse Specialist St James’s Hospital, Leeds.

Module 4: Testing and monitoring. Module 5: Testing and monitoring Module goal To introduce participants to best practice regarding the different tests,

HBV. Overview of the Epidemiology of Hepatotropic Viruses.

Where Are We on the Path to Elimination of Chronic Hepatitis C?

EASL Recommendations on Treatment of Hepatitis C 2015 Treatment recommendations for HCV-monoinfected or HCV/HIV coinfected patients with chronic hepatitis.

3rd International HIV/Viral Hepatitis Co-Infection Meeting HIV/Viral Hepatitis: Improving Diagnosis, Antiviral Therapy and Access Sunday, 17 July.

Diagnosis and Point of Care Testing of Hepatitis C

Talking to Patients About HCV Treatment

A Review of the Critical Role of Imaging in Primary Liver Malignancy

Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.

HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.

Chronic Hepatitis C Virus Infection

Starting Strong: Initial Evaluation of the Patient With HCV

Is it Flu? Advances in Diagnostic Strategies and Implications for Patient Care.

Essential Updates in Atopic Dermatitis:

Extrahepatic Manifestations of HCV Infection

HCV: Who Should We Screen and Why?

More Than Meets the Eye: Identifying Who Is at Risk for NASH

Building Health Systems to Deliver People-centered Health Services

World Epidemiology. Are HIV and Other Chronic Diseases Models Applicable to Viral Hepatitis? Focus on HCV.

Overview of Disparities

The HCV Revolution: Are You and Your Practice Ready?

Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.

Best Practices in Screening and Linkage to Care in Hepatitis C Virus

Ending HCV: How Do We Get There From Here?

More Than Treatment.

HBV Care Models: Community Collaborations for Best Practices

Evaluation of the Patient With HCV Infection

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

Immunization Against Varicella:

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

Glaucoma: Detect, Diagnose, And Monitor The Silent Thief of Vision

Tackling Atopic Dermatitis

HIV Treatment: What Can You Do to Get and Keep Patients in Care?

CMV in the HSCT Recipient

Impact of metabolic risk factors on HCC

Hepatitis C: After the Diagnosis

Challenges in Severe Asthma

Marc Boucher, MD, DABOG (MFM)

Understanding the Updated Guidelines for ALK Testing in NSCLC

Managing Age-Related Clinical Issues in Hemophilia

Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.

A Guideline-Based Approach to HCV Care

Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.

Are We Making Progress in the Management of Huntington Disease?

Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.

Hepatitis C Virus Diagnosis and the Holy Grail

THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES

Championing Evidence-Based Care in Patients With Acute Low Back Pain

MS, Age, and Immune Function

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Tardive Dyskinesia 101.

The Building Blocks of Homocystinuria and Homocysteinemia Management

NAFLD and NASH in Europe and Canada

Ask the Psoriasis Expert

Hematopoietic stem cell transplantation in HCV-infected patients

Foundations of Asthma.

Managing Hepatitis C in Vermont

Motor Fluctuations in PD

Presentation transcript:

Removing Barriers in the HCV Cascade of Care

Program Overview

HCV Burden of Disease

Worldwide HCV Prevalence (2015)

Global Annual Mortality

Disability From Liver Disease Has Increased (2006-2016)

Outline of HCV Long-Term Complications Natural History of Hepatitis C

Progression to Cirrhosis

Progression to Cirrhosis (cont)

Extrahepatic Manifestations of HCV Infection

Improving the HCV Cascade of Care

WHO Vision

HCV Cascade of Care (British Columbia, Canada)

HCV Cascade of Care (British Columbia, Canada) (cont)

HCV Cascade of Care (British Columbia, Canada) (cont)

Screening Strategies

ELISA Assays

NAT Testing (rtPCR or TMA)

Point-of-Care Tests

Rapid Diagnostic Tests (RDT)

Dried Blood Spots (DBS)

Confirmation of Replication

Screening Linkage to Care

Decentralized Screening and Care

Simplified Pretherapeutic Assessment

EASL Recommendations on the Treatment of Hepatitis C 2018

Treatment Monitoring

Simplified Treatment Monitoring

HCV Elimination Strategies

HCV Elimination Strategies

HCV Elimination Strategies

Micro-Elimination Target Groups

US Veterans

Concluding Remarks

Abbreviations

Abbreviations (cont)